rawfin.tv
Palisade Bio CEO, CFO Sells $303K in Stock for Tax Obligations
MarketsstocksAI Generated

Palisade Bio CEO, CFO Sells $303K in Stock for Tax Obligations

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

John David Finley, CEO and CFO of Palisade Bio, sold 146,798 shares of company stock, totaling $303,343. The sale was conducted to cover tax obligations arising from vested equity.

PALIInsider SellingBiotechnologyExecutive Compensation

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks